← Back to directory

Hinrich Abken

Researcher Next ID · RN-028830

Researcher · Medicine

Leibniz Association

Berlin, Chile

Not currently recruitingFunding unknown
Works count
368
Citation count
13,655
H-index
66
i10-index
189

Research interests

Medicine
Immunology and Microbiology
Biochemistry, Genetics and Molecular Biology
CAR-T cell therapy research
Immune Cell Function and Interaction
Immunotherapy and Immune Responses
Monoclonal and Polyclonal Antibodies Research
Virus-based gene therapy research

Publications

  • CAR T Cells Releasing IL-18 Convert to T-Bethigh FoxO1low Effectors that Exhibit Augmented Activity against Advanced Solid Tumors

    Cell Reports · 2017 · https://doi.org/10.1016/j.celrep.2017.11.063

  • TRUCKs: the fourth generation of CARs

    Expert Opinion on Biological Therapy · 2015 · https://doi.org/10.1517/14712598.2015.1046430

  • Of CAR s and TRUCK s: chimeric antigen receptor ( CAR ) T cells engineered with an inducible cytokine to modulate the tumor stroma

    Immunological Reviews · 2013 · https://doi.org/10.1111/imr.12125

  • IL-12 Release by Engineered T Cells Expressing Chimeric Antigen Receptors Can Effectively Muster an Antigen-Independent Macrophage Response on Tumor Cells That Have Shut Down Tumor Antigen Expression

    Cancer Research · 2011 · https://doi.org/10.1158/0008-5472.can-11-0103

  • Tumor-Specific T Cell Activation by Recombinant Immunoreceptors: CD3ζ Signaling and CD28 Costimulation Are Simultaneously Required for Efficient IL-2 Secretion and Can Be Integrated Into One Combined CD28/CD3ζ Signaling Receptor Molecule

    The Journal of Immunology · 2001 · https://doi.org/10.4049/jimmunol.167.11.6123

Current projects

    No projects listed.